← FDA Drug Approvals (Drugs@FDA)

ERYTHROCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ABBOTT · Approved 1988-01-04

Drug application

FDA Application #

ANDA062586

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROCIN

Generic name

Erythromycin Lactobionate

Active ingredients

ERYTHROMYCIN LACTOBIONATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

ABBOTT

First approval

1988-01-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown